Flagship Harbor Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Flagship Harbor Advisors’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Sell	5,632 -793	-12%	-$27.6K	0.01%	718
2026 Q1	$221K	Buy	6,425 +200	+3%	+$6.83K	0.01%	681
2025 Q4	$205K	Buy	+6,225	New	+$194K	0.01%	651
2021 Q2	–	Sell	-10,260	Closed	-$262K	–	646
2021 Q1	$262K	Sell	10,260 -6,882	-40%	-$180K	0.03%	523
2020 Q4	$442K	Buy	+17,142	New	+$427K	0.05%	336

Other funds holding FTXH

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Flagship Harbor Advisors's FTXH Position: Q2 2026 in Review

Flagship Harbor Advisors reduced its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 12% in Q2 2026, selling an estimated $27.6K and leaving 5,632 shares worth $215K. The position accounts for 0.01% of the portfolio, ranked #718.

Flagship Harbor Advisors first reported a position in FTXH in Q4 2020 and has held it in 5 quarters since. The position peaked at $442K in Q4 2020. 31 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Flagship Harbor Advisors held 5,632 shares of First Trust Nasdaq Pharmaceuticals ETF worth $215K as of Q2 2026.
Flagship Harbor Advisors sold 793 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $27.6K.
First Trust Nasdaq Pharmaceuticals ETF made up 0.01% of Flagship Harbor Advisors's portfolio in Q2 2026, its #718 holding.
Flagship Harbor Advisors first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2020 and has held it in 5 quarters since.
Flagship Harbor Advisors's First Trust Nasdaq Pharmaceuticals ETF position peaked at $442K in Q4 2020.
31 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.